The estimated Net Worth of Venture Associates X, L.P.A... is at least $4.64 Milión dollars as of 21 June 2021. Venture A owns over 185,078 units of Generation Bio Co stock worth over $1,625 and over the last 3 years Venture sold GBIO stock worth over $4,636,204.
Venture has made over 1 trades of the Generation Bio Co stock since 2021, according to the Form 4 filled with the SEC. Most recently Venture sold 185,078 units of GBIO stock worth $4,636,204 on 21 June 2021.
The largest trade Venture's ever made was selling 185,078 units of Generation Bio Co stock on 21 June 2021 worth over $4,636,204. On average, Venture trades about 185,078 units every 0 days since 2021. As of 21 June 2021 Venture still owns at least 666 units of Generation Bio Co stock.
You can see the complete history of Venture A stock trades at the bottom of the page.
Over the last 4 years, insiders at Generation Bio Co have traded over $37,722,950 worth of Generation Bio Co stock and bought 4,282,125 units worth $70,408,633 . The most active insiders traders include Jason P Rhodes, Biomedical Innovation Maste... a Public Equities, L.P.Minne .... On average, Generation Bio Co executives and independent directors trade stock every 11 days with the average trade being worth of $116,471. The most recent stock trade was executed by Yalonda Howze on 15 July 2024, trading 3,347 units of GBIO stock currently worth $8,167.
Generation Bio Co., a genetic medicines company, develops gene therapies for the treatment of rare and prevalent diseases. The company is developing a portfolio of programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
Generation Bio Co executives and other stock owners filed with the SEC include: